Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Wahler

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Pharmacology Reports|October 7, 2015
Targeting HER2 Positive Breast Cancer with Chemopreventive AgentsJoseph Wahler, Nanjoo Suh
Oncotarget|February 4, 2016
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancerTae-Hwe Heo, Joseph Wahler, Nanjoo Suh
Seminars in Cancer Biology|March 27, 2016
Role of dietary bioactive natural products in estrogen receptor-positive breast cancerMin Ji Bak, Soumyasri Das Gupta, Joseph Wahler, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 3, 2014
Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancerJoseph Wahler, Jae Young So, Larry C Cheng, et al.
Plos One|September 18, 2014
A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancerJae Young So, Janice J Lin, Joseph Wahler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 3, 2014
Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analogJoseph Wahler, Jae Young So, Yeoun Chan Kim, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 27, 2014
HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancerJae Young So, Joseph Wahler, Soumyasri Das Gupta, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 8, 2016
Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancerNaing Lin Shan, Joseph Wahler, Hong Jin Lee, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 19, 2017
Inhibitory Effects of γ- and δ-Tocopherols on Estrogen-Stimulated Breast Cancer <i>In Vitro</i> and <i>In Vivo</i>Min Ji Bak, Soumyasri Das Gupta, Joseph Wahler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 4, 2017
Differential Gene Regulation and Tumor-Inhibitory Activities of Alpha-, Delta-, and Gamma-Tocopherols in Estrogen-Mediated Mammary CarcinogenesisSoumyasri Das Gupta, Misaal Patel, Joseph Wahler, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Pharmacology Reports|October 7, 2015
Targeting HER2 Positive Breast Cancer with Chemopreventive AgentsJoseph Wahler, Nanjoo Suh
Oncotarget|February 4, 2016
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancerTae-Hwe Heo, Joseph Wahler, Nanjoo Suh
Seminars in Cancer Biology|March 27, 2016
Role of dietary bioactive natural products in estrogen receptor-positive breast cancerMin Ji Bak, Soumyasri Das Gupta, Joseph Wahler, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 3, 2014
Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancerJoseph Wahler, Jae Young So, Larry C Cheng, et al.
Plos One|September 18, 2014
A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancerJae Young So, Janice J Lin, Joseph Wahler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 3, 2014
Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analogJoseph Wahler, Jae Young So, Yeoun Chan Kim, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 27, 2014
HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancerJae Young So, Joseph Wahler, Soumyasri Das Gupta, et al.
The Journal of Steroid Biochemistry and Molecular Biology|December 8, 2016
Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancerNaing Lin Shan, Joseph Wahler, Hong Jin Lee, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 19, 2017
Inhibitory Effects of γ- and δ-Tocopherols on Estrogen-Stimulated Breast Cancer <i>In Vitro</i> and <i>In Vivo</i>Min Ji Bak, Soumyasri Das Gupta, Joseph Wahler, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 4, 2017
Differential Gene Regulation and Tumor-Inhibitory Activities of Alpha-, Delta-, and Gamma-Tocopherols in Estrogen-Mediated Mammary CarcinogenesisSoumyasri Das Gupta, Misaal Patel, Joseph Wahler, et al.
Pageof 2